Skip to main content

Table 5 Treatment outcomes among HIV-negative patients with and without underlying disease

From: Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study

Variables Group D (N = 18) Group ND (N = 25) P-values
Treatment received 14 23 0.378
Deterioration (discontinue treatment) 4 2  
Medication
-Amphotericin B then itraconazole 5 6 1.000
-Itraconazole 4 2 0.378
-Fluconazole then itraconazole 4 10 0.220
-Voriconazole 1 5 0.367
Outcome, n (%) 0.022*
-Cure 5 (27.78) 13 (52 %)  
-Recovery 6 (33.33 %) 7 (28 %)  
-Dead 8 (44.44 %) 3 (12 %)  
  1. Patients with Penicillium marneffei infection were divided into two groups; Group D included patients with underlying disease, and Group ND included patients without underlying disease
  2. *P < 0.05
  3. Data are presented as the number of patients, unless otherwise indicated